ReviewTranslational lung cancer research2015

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.

Erin L Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.